Search results
Showing 556 to 570 of 735 results for adult social
NICE has developed a medtech innovation briefing (MIB) on RT300 for spinal cord injury rehabilitation .
YOURmeds for medication support in long-term conditions (MIB289)
NICE has developed a medtech innovation briefing (MIB) on YOURmeds for medication support in long-term conditions .
Training for hospital and social care practitioners:- What is the effect of hospital discharge or transitions training for health and...
Evidence-based recommendations on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care.
functioning (social skills) for people with complex psychosis? Any explanatory notes(if applicable) Interpersonal and...
problems in people with learning disabilities, for routine use in primary care, social care and education settings. Any explanatory...
an assessment in hospital with a home assessment after discharge, from a social care needs perspective for different populations. In...
compared with specialist units. Costs need to include the use of health and social care resources (including in the community and care...
or preferable from their point of view. Groups with different health or social care needs may need different approaches.Research is...
group's needs in hospital and in specialist units, and the cost of health and social care, unpaid care, and the effects on employment...
Evidence-based recommendations on bempedoic acid with ezetimibe (Nilemdo and Nustendi) for treating primary hypercholesterolaemia or mixed dyslipidaemia as an adjunct to diet in adults.
Evidence-based recommendations on leniolisib (Joenja) for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over.
loss and discomfort, contributes to infections, and can exacerbate stress, social isolation and depression. Moreover, earwax can prevent...
Berotralstat for preventing recurrent attacks of hereditary angioedema (TA738)
Evidence-based recommendations on berotralstat (Orladeyo) for preventing recurrent attacks of hereditary angioedema in people 12 years and older.
Dupilumab for treating moderate to severe atopic dermatitis (TA534)
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults.